5'-substituted adenosine analogs as new high-affinity partial agonists for the adenosine A1 receptor

Journal of Medicinal Chemistry

Volumn 41, Issue 1, 1998, Pages 102-108

  Van der Wenden, Eleonora M ^a   Carnielli, Marta ^a   Roelen, Harlof C P F ^a   Lorenzen, Anna ^b   Von Frijtag Drabbe Künzel, Jacobien K ^a   Izerman, Adriaan P ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b Pharmakologisches Institut   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 6 N CYCLOPENTYLADENOSINE; 6 N CYCLOPENTYLADENOSINE DERIVATIVE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE A2 RECEPTOR; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN MEMBRANE; CORONARY ARTERY DISEASE; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; NONHUMAN; RAT; RECEPTOR AFFINITY;

ADENOSINE; ANIMALS; BRAIN; CELL MEMBRANE; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); KINETICS; RATS; RECEPTOR, ADENOSINE A2A; RECEPTORS, PURINERGIC P1; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0031894806     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm970508l     Document Type: Article

References (42)

1. Jacobson, K. A.; Van Galen, P. J. M.; Williams, M. Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential. J. Med. Chem. 1992, 35, 407-422.
2. Jacobson, K. A.; Van Rhee, A. M. Development of selective purinoceptor agonists and antagonists. Purinergic approaches in experimental therapeutics; Jacobson, K. A., Jarvis, M. F., Eds.; Wiley-Liss: New York, 1997; pp 101-128.
3. Stiles, G. L. Adenosine receptor subtypes: new insights from cloning and functional studies. Purinergic approaches in experimental therapeutics; Jacobson, K. A., Jarvis, M. F., Eds.; WileyLiss: New York, 1997; pp 29-37.
4. Erion, M. D. Adenosine receptors as pharmacological tools. Annu. Rep. Med. Chem. 1993, 28, 295-305.
5. Olsson, R. A.; Khouri, E. M.; Bedynek, J. L., Jr.; McLean, J. Coronary vasoactivity of adenosine in the conscious dog. Circ. Res. 1979, 45, 468-478.
6. 3 receptors mediate hypotension in the angiotensin II-supported circulation of the pithed rat. Br. J. Pharmacol. 1993, 109, 3-5.
7. 6-cyclopentyladenosine (CPA) in the rat. J. Pharmacol. Exp. Ther. 1994, 268, 616-624.
8. IJzerman, A. P.; Van der Wenden, E. M.; Mathôt, R. A. A.; Danhof, M.; Borea, P. A.; Varani, K., Partial agonism of theophylline-7-riboside on adenosine receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 1994, 350, 638-645.
9. 6-(ω-aminoalkyl)adenosins on adenosine receptor affinity and intrinsic activity. Eur. J. Pharmacol.-Mol. Pharmacol. Sect. 1989, 172, 185-193.
10. IJzerman, A. P.; Van der Wenden, E. M.; Mathôt, R. A. A.; Danhof, M.; Borea, P. A.; Varani, K. Theophylline-7-riboside: a partial agonist for adenosine receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 1994, 350, 638-645.
11. 1 receptor. Eur. J. Pharmacol.-Mol. Pharmacol. Sect. 1995, 290, 189-199.
12. Van der Wenden, E. M.; Von Frijtag Drabbe Künzel, J. K.; Mathôt, R. A. A.; Danhof, M.; IJzerman, A. P.; Soudijn. W. Ribose-modified adenosine analogues as potential partial agonists for the adenosine receptor. J. Med. Chem. 1995, 38, 4000-4006.
13. 1 receptor in vivo. Br. J. Pharmacol. 1995, 116, 1957-1964.
14. 1 receptor in vivo. J. Pharmacol. Exp. Ther. 1996, 279, 1439-1446.
15. IJzerman, A. P.; Van der Wenden, E. M.; Roelen, H. C. P. F.; Mathôt, R. A. A.; Von Frijtag Drabbe Künzel, J. K. Partial agonists for adenosine receptors. Perspectives in Receptor Research; Elsevier Science: New York, 1996; pp 181-192.
16. 1 receptors. J. Med. Chem. 1996, 39, 1463-1471.
17. 3H]NECA in rat striatal membranes. Mol. Pharmacol. 1986, 29, 331-346.
18. Prasad, R. J.; Bariana, D. S.; Fung, A.; Savic, M.; Tietje, K. Modification of the 5′ position of purine nucleosides. 2. Synthesis and some cardiovascular properties of adenosine-5′-(N-substituted)carboxamides. J. Med. Chem. 1980, 23, 313-319.
19. 2 selective adenosine receptor agonist with preferential hypotensive activity. J. Pharmacol. Exp. Ther. 1989, 251, 47-55.
20. 3 receptor. Mol. Pharmacol. 1994, 45, 1101-1111.
21. 2-adenosine receptors coupled to adenylate cyclase. Biochem. Pharmacol 1992, 43, 1089-1093.
22. Taylor, M. D.; Moos, W. H.; Hamilton, H. W.; Szotek, D. S.; Patt, W. C.; Badger, E. W.; Bristol, J. A.; Bruns, R. F.; Heffner, T. G.; Mertz, T. E. Ribose-modified adenosine analogues as adenosine receptor agonists. J. Med. Chem. 1986, 29, 346-353.
23. Kikugawa, K.; Ichino, M. Direct halogenation of sugar moiety of nucleosides. Tetrahedron Lett. 1971, 87-90.
24. Nakagawa, I.; Hata, T. A convenient method for the synthesis of 5′-S-alkylthio-5′-deoxyribonucleosides, Tetrahedron Lett. 1975, 1409-1412.
25. Baddiley, J.; Jamieson, G. A. Synthesis of "active methionine". J. Chem. Soc. 1954, 4280-4284.
26. Srivastava, P. C.; Robins, R. K.; Meyer, R. B., Jr. Synthesis and properties of purine nucleosides and nucleotides. Chemistry of nucleosides and nucleotides, 1; Townsend, L. B., Ed.; Plenum Press: New York, 1988; pp 113-282.
27. Levene, P. A.; Stuart Tipson, R. The structure of monotrityl uridine. J. Biol. Chem. 1934, 105, 419-429.
28. Kolb, M.; Danzin, C.; Barth, J.; Claverie, N. Synthesis and biochemical properties of chemically stable product analogues of the reaction catalyzed by S-adenosyl-L-methionine decarboxylase. J. Med. Chem. 1982, 25, 550-556.
29. Minnick, A. A.; Kenyon, G. L. General synthetic approach to stable nitrogen analogues of S-adenosylmethionine. J. Org. Chem. 1988, 53, 4952-4961.
30. 6-substituted adenosines: synthesis, biological activity, and some structure-activity relationships. J. Med. Chem. 1972, 15, 187-191.
31. 6-Substituted adenosines. J. Med. Chem. 1973, 16, 348-364.
32. Kikugawa, K.; Iizuka, K.; Higuchi, Y.; Hirayama, H.; Ichino, M. Platelet Aggregation inhibitors. 2. Inhibition of platelet aggregation by 5′-, 2-, 6-, and 8-substituted adenosines. J. Med. Chem. 1972, 15, 387-390.
33. 6,5′disubstituted adenosine derivatives from inosine. Nucleosides Nucleotides 1988, 7, 375-383.
34. Ogilvie, K. K.; Beaucage, S. L.; Schifman, A. L.; Theriault, N. Y.; Sadana, K. The synthesis of oligonucleotides. II. The use of silyl protecting groups in nucleoside and nucleotide chemistry. VII. Can. J. Chem. 1978, 56, 2768-2776.
35. Davisson, V.; Davis D. R.; Dixit, V. M.; Poulter, C. D. Synthesis of nucleotide 5′-diphosphates from 5′-O-tosyl nucleosides. J. Org. Chem. 1987, 52, 1794-1801.
36. Lohse, M. J.; Lenschow, V.; Schwabe, U. Interaction of barbiturates with adenosine receptors in rat brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 1984, 326, 69-74.
37. Smith, P. K.; Krohn, R. I.; Hermanson, G. T.; Mallia, A. K.; Gartner, E. H.; Provenzano, M. D.; Fujimoto, E. K.; Goeke, N. M.; Olson, B. J.; Klenk, D. C. Measurement of protein using bicinchoninic acid. Anal. Biochem. 1985, 150, 76-85.
38. 1 adenosine receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 1987, 336, 204-210.
39. 3H in various regions of the brain, J. Neurochem. 1966, 13, 65-69.
40. 2 receptors in rat striatum. Biochem. Pharmacol. 1992, 44, 2365-2370.
41. S]thio)triphosphate binding. Mol. Pharmacol. 1993, 44, 115-123.
42. 1 adenosine receptor with receptor/G protein complexes in rat brain membranes. Mol. Pharmacol. 1996, 49, 915-926.